Trial Profile
To evaluate Clinical and Economic Benefits of Fidaxomicin Compared to Vancomycin for Clostridium difficile Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2017
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary) ; Vancomycin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 07 Nov 2017 New trial record